These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23469298)

  • 1. The household costs of visceral leishmaniasis care in south-eastern Nepal.
    Uranw S; Meheus F; Baltussen R; Rijal S; Boelaert M
    PLoS Negl Trop Dis; 2013; 7(2):e2062. PubMed ID: 23469298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of visceral leishmaniasis for households in Nepal.
    Rijal S; Koirala S; Van der Stuyft P; Boelaert M
    Trans R Soc Trop Med Hyg; 2006 Sep; 100(9):838-41. PubMed ID: 16406035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The economic impact of visceral leishmaniasis on households in Bangladesh.
    Anoopa Sharma D; Bern C; Varghese B; Chowdhury R; Haque R; Ali M; Amann J; Ahluwalia IB; Wagatsuma Y; Breiman RF; Maguire JH; McFarland DA
    Trop Med Int Health; 2006 May; 11(5):757-64. PubMed ID: 16640630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs.
    Meheus F; Abuzaid AA; Baltussen R; Younis BM; Balasegaram M; Khalil EAG; Boelaert M; Musa AM
    Am J Trop Med Hyg; 2013 Dec; 89(6):1146-1153. PubMed ID: 24189368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.
    Meheus F; Boelaert M; Baltussen R; Sundar S
    Trop Med Int Health; 2006 Nov; 11(11):1715-24. PubMed ID: 17054752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL-program districts with non-program districts.
    Lim D; Banjara MR; Singh VK; Joshi AB; Gurung CK; Das ML; Matlashewski G; Olliaro P; Kroeger A
    Trop Med Int Health; 2019 Feb; 24(2):192-204. PubMed ID: 30565348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paying for hospital-based care of Kala-azar in Nepal: assessing catastrophic, impoverishment and economic consequences.
    Adhikari SR; Maskay NM; Sharma BP
    Health Policy Plan; 2009 Mar; 24(2):129-39. PubMed ID: 19181674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study.
    Poudel AN; Newlands D; Simkhada P
    BMC Health Serv Res; 2017 Jan; 17(1):76. PubMed ID: 28118830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.
    Mondal D; Singh SP; Kumar N; Joshi A; Sundar S; Das P; Siddhivinayak H; Kroeger A; Boelaert M
    PLoS Negl Trop Dis; 2009; 3(1):e355. PubMed ID: 19159009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
    Thornton SJ; Wasan KM; Piecuch A; Lynd LL; Wasan EK
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1312-9. PubMed ID: 20545513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of Pediatric Visceral Leishmaniasis Care in Morocco.
    Tachfouti N; Najdi A; Alonso S; Sicuri E; Laamrani El Idrissi A; Nejjari C; Picado A
    PLoS One; 2016; 11(6):e0155482. PubMed ID: 27257808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010).
    Uranw S; Ostyn B; Rijal A; Devkota S; Khanal B; Menten J; Boelaert M; Rijal S
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1433. PubMed ID: 22206030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of visceral leishmaniasis in rural primary health care services in Bihar, India.
    Hasker E; Singh SP; Malaviya P; Singh RP; Shankar R; Boelaert M; Sundar S
    Trop Med Int Health; 2010 Jul; 15 Suppl 2(Suppl 2):55-62. PubMed ID: 20591081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline.
    Rijal S; Chappuis F; Singh R; Bovier PA; Acharya P; Karki BM; Das ML; Desjeux P; Loutan L; Koirala S
    Trans R Soc Trop Med Hyg; 2003; 97(3):350-4. PubMed ID: 15228258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India.
    Boettcher JP; Siwakoti Y; Milojkovic A; Siddiqui NA; Gurung CK; Rijal S; Das P; Kroeger A; Banjara MR
    BMC Infect Dis; 2015 Feb; 15():43. PubMed ID: 25656298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "It's just a fever": Gender based barriers to care-seeking for visceral leishmaniasis in highly endemic districts of India: A qualitative study.
    Jayakumar B; Murthy N; Misra K; Burza S
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007457. PubMed ID: 31247011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of visceral leishmaniasis care in Brazil.
    de Carvalho IPSF; Peixoto HM; Romero GAS; de Oliveira MRF
    Trop Med Int Health; 2017 Dec; 22(12):1579-1589. PubMed ID: 29078015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.
    Joshi AB; Das ML; Akhter S; Chowdhury R; Mondal D; Kumar V; Das P; Kroeger A; Boelaert M; Petzold M
    BMC Med; 2009 Oct; 7():54. PubMed ID: 19804620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.
    Singh SP; Hirve S; Huda MM; Banjara MR; Kumar N; Mondal D; Sundar S; Das P; Gurung CK; Rijal S; Thakur CP; Varghese B; Kroeger A
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e960. PubMed ID: 21347452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evidence supports the expansion of visceral leishmaniasis towards non-program districts of Nepal.
    Shrestha M; Khatri-Chhetri M; Poudel RC; Maharjan J; Dumre SP; Manandhar KD; Pandey BD; Pun SB; Pandey K
    BMC Infect Dis; 2019 May; 19(1):444. PubMed ID: 31113385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.